All CIRS research papers

7,510 papers, newest first · page 85 of 126

  1. Erythropoietin as a Tissue-Protective Cytokine in Brain Injury: What Do We Know and Where Do We Go?

    The Neuroscientist · 2004

  2. Effect of pioglitazone treatment in a patient with secondary multiple sclerosis

    Journal of Neuroinflammation · 2004

  3. Erythropoietin as a novel neuroprotectant

    Restorative neurology and neuroscience · 2004

  4. Modulating the hypoxia-inducible factor signaling pathway: applications from cardiovascular disease to cancer

    Current Pharmaceutical Design · 2004

  5. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity

    Neurobiology of Disease · 2004

  6. Erythropoietin in the brain: can the promise to protect be fulfilled?

    Trends in Pharmacological Sciences · 2004

  7. Beneficial and ominous aspects of the pleiotropic action of erythropoietin

    Annals of Hematology · 2004

  8. Epotin alfa: clinical evolution of a pleiotropic cytokine

    Arch Intern Med · 2004

  9. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection

    Cardiovascular Research · 2004

  10. Regulation of fatty acid transport by fatty acid translocase/CD36

    Proceedings of The Nutrition Society · 2004

  11. Therapeutic Effects of Angiotensin (AT1) Receptor Antagonists

    American Journal of Cardiovascular Drugs · 2004

  12. Acquisition of anergic and suppressive activities in transforming growth factor- -costimulated CD4+CD25- T cells

    International Immunology · 2004

  13. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer

    Immunologic Research · 2004

  14. Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

    European Journal of Immunology · 2004

  15. http://cfpub2.epa.gov/ordpubs/nerlpubs/nerlpubs_mcear_2004.cfm?ActType=Pu CDC/New Orleans

    Exposure of children to indoor molds. EPA Science Forum · 2004

  16. Dampness in buildings and health (DBH): report from an ongoing epidemiological investigation on the association between indoor environmental factors and health effects among children in Sweden

    Indoor Air · 2004

  17. Characterization of Mold and Moisture Indicators in the Home

    Journal of Occupational and Environmental Hygiene · 2004

  18. Emission exposure model for the transport of toxic mold

    Indoor and Built Environment · 2004

  19. Air- and Dustborne Mycoflora in Houses Free of Water Damage and Fungal Growth

    Applied and Environmental Microbiology · 2004

  20. Exposure assessment and analysis for biological agents

    Grana · 2004

  21. Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments

    Archives of Environmental Health An International Journal · 2004

  22. Protein Translation Inhibition by Stachybotrys chartarum Conidia with and without the Mycotoxin Containing Polysaccharide Matrix

    Mycopathologia · 2004

  23. Biological Effects of Trichoderma harzianum Peptaibols on Mammalian Cells

    Applied and Environmental Microbiology · 2004

  24. Risk from inhaled mycotoxins in indoor office and residential environments

    International Journal of Toxicology · 2004

  25. Attributes of Stachybotrys chartarum and its association with human disease

    Journal of Allergy and Clinical Immunology · 2004

  26. Filamentous microorganisms and their fragments in indoor air- a review

    Annals of agricultural and environmental medicine · 2004

  27. Comparison of the toxicity of reference mycotoxins and spore extracts of common indoor moulds. International Journal of Hygience and Environmental Health

    2004

  28. Cognitive impairment associated with toxigenic fungal exposure: a replication and extension of previous findings

    Applied Neuropsychology · 2004

  29. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure

    Archives of Environmental Health An International Journal · 2004

  30. Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxins roridin A: kinetics and potentiation by bacterial lipopolysaccharide co-exposure. ToxSci Advance Access May 2004

    Toxicological Sciences · 2004

  31. Immunity to fungal infections

    Nature Reviews/Immunology · 2004

  32. Possible role of fungal hemolysins in sick building syndrome

    Advances in applied microbiology · 2004

  33. Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor

    Journal of Biological Chemistry · 2004

  34. Neuroprotection by transforming growth factor-β1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways

    Neuroscience · 2004

  35. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor‐beta 1 in astrocytes from distinct brain regions

    European Journal of Neuroscience · 2004

  36. The anti-inflammatory response dominates after septic shock; association of low monocyte hla-dr expression and high interleukin-10 concentration

    Immunology Letters · 2004

  37. Cytokine production and monocyte hla-dr expression as predictors of outcome for patients with community-acquired severe infections

    Clinical and Vaccine Immunology · 2004

  38. Mononuclear Histocompatibility Leukocyte Antigen-DR Expression in the Early Phase of Acute Pancreatitis

    Pancreatology · 2004

  39. Plasma anti‐inflammatory cytokines and monocyte human leucocyte antigen‐DR expression in patients with acute pancreatitis

    Scandinavian Journal of Gastroenterology · 2004

  40. Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure

    Clinical Nephrology · 2004

  41. Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate

    Leukemia · 2004

  42. Modifying RESA protein peptide 6671 to fit into HLA-DRβ1* pockets induces protection against malaria

    Biochemical and Biophysical Research Communications · 2004

  43. Preimplantation HLA testing

    JAMA · 2004

  44. The abc’s of artificial antigen presentation

    Nature Biotechnology · 2004

  45. Association of medically unexplained fatigue with ACE insertion/deletion polymorphism in Gulf War veterans

    Muscle & Nerve · 2004

  46. Scientists identify genes that regulate allergic response to diesel fumes. NIH News, 01/08/2004

    2004

  47. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo

    Immunity · 2004

  48. Molecular Analysis of HLA Class ll-Associated Susceptibility to Neuroinflammatory Diseases in Korean Children

    Journal of Korean Medical Science · 2004

  49. Bordetella pertussisInfection of Primary Human Monocytes Alters HLA-DR Expression

    Infection and Immunity · 2004

  50. Toll-Like Receptor 4-Dependent Early Elicited Tumor Necrosis Factor Alpha Expression Is Critical for Innate Host Defense againstBordetella bronchiseptica

    Infection and Immunity · 2004

  51. Mucosal administration of flagellin induces innate immunity in the mouse lung

    Infection and Immunity · 2004

  52. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase

    Infection and Immunity · 2004

  53. Dendritic Cells Stimulated withActinobacillus actinomycetemcomitansElicit Rapid Gamma Interferon Responses by Natural Killer Cells

    Infection and Immunity · 2004

  54. Suppression of Serum Antibody Responses by Pertussis Toxin after Respiratory Tract Colonization byBordetella pertussisand Identification of an Immunodominant Lipoprotein

    Infection and Immunity · 2004

  55. Cytokine Response to Infection with Bacillus anthracis Spores

    Infection and Immunity · 2004

  56. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity

    Infection and Immunity · 2004

  57. Membrane Restructuring by Bordetella pertussis Adenylate Cyclase Toxin, a Member of the RTX Toxin Family

    Journal of Bacteriology · 2004

  58. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages

    Infection and Immunity · 2004

  59. W01.43 Evidence for anti-inflammatory activity of statins and fibrates from studies in human C-reactive protein transgenic mice and in cultured human hepatocytes

    Blood · 2004

  60. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation

    The Journal of Immunology · 2004